Results
26
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
26 companies
Genomed Spólka Akcyjna
Market Cap: zł37.8m
Provides DNA sequencing and analysis, and diagnostics of congenital diseases in Poland.
GEN
zł28.60
7D
4.4%
1Y
3.6%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł222.8m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł40.40
7D
10.4%
1Y
-46.6%
Poltreg
Market Cap: zł121.2m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł26.00
7D
0%
1Y
-52.7%
Read-Gene
Market Cap: zł72.9m
Engages in the detection, prevention, and treatment of various types of cancer.
RDG
zł6.20
7D
1.3%
1Y
12.3%
Molecure
Market Cap: zł150.1m
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland.
MOC
zł7.37
7D
-1.6%
1Y
-42.0%
Selvita
Market Cap: zł704.9m
Operates as a contract research organization worldwide.
SLV
zł38.20
7D
0.8%
1Y
-33.6%
Biogened
Market Cap: zł59.0m
Develops, produces, and distributes pharmaceutical products in Poland.
BGD
zł24.00
7D
-3.2%
1Y
4.3%
Vinci Gen
Market Cap: zł2.9m
Engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.
VGN
zł0.24
7D
-10.4%
1Y
-50.4%
Stem Cells Spin
Market Cap: zł18.0m
Operates as a biotechnology company in Poland.
SCS
zł0.41
7D
-2.9%
1Y
94.3%
HyEnergy
Market Cap: zł77.9m
Provides genetic diagnostic solutions in Poland.
HEN
zł2.32
7D
0%
1Y
-22.4%
genXone
Market Cap: zł18.2m
Operates in the biotechnology industry in Poland and internationally.
GX1
zł5.56
7D
-5.4%
1Y
-8.3%
BIOTON
Market Cap: zł384.7m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł4.43
7D
-1.6%
1Y
30.3%
Labocanna
Market Cap: zł5.8m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.27
7D
-5.9%
1Y
-30.2%
Green Zebras Spolka Akcyjna
Market Cap: zł12.0m
Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.
GRZ
zł9.10
7D
4.0%
1Y
-39.5%
NanoGroup
Market Cap: zł86.1m
Operates as a biotechnology company in Poland.
NNG
zł2.74
7D
-2.8%
1Y
-32.8%
Bioceltix
Market Cap: zł498.4m
Engages in the development of stem cell-based biopharmaceuticals for veterinary use.
BCX
zł101.40
7D
-3.2%
1Y
49.1%
Cannabis Poland
Market Cap: zł14.7m
Engages in the retail and wholesale of products based on hemp containing cannabidiol (CBD) in Poland.
CBD
zł0.29
7D
0.3%
1Y
-45.3%
Urteste
Market Cap: zł65.8m
Engages in the research and development of diagnostic tests for cancers.
URT
zł44.60
7D
-1.8%
1Y
-49.3%
Celon Pharma
Market Cap: zł1.2b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.
CLN
zł21.80
7D
-0.5%
1Y
-20.6%
Genomtec
Market Cap: zł104.5m
Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.
GMT
zł6.93
7D
0.1%
1Y
-7.2%
Medicofarma Biotech
Market Cap: zł53.6m
A biotechnology company, provides medicines, medicinal products, and biotechnology products.
MDB
zł0.77
7D
-5.9%
1Y
45.6%
Mabion
Market Cap: zł139.6m
A biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.
MAB
zł8.60
7D
-3.6%
1Y
-47.5%
Ryvu Therapeutics
Market Cap: zł513.0m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł27.80
7D
1.5%
1Y
-46.9%
Pure Biologics
Market Cap: zł25.7m
A biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases.
PUR
zł6.29
7D
-0.7%
1Y
-70.0%
Synthaverse
Market Cap: zł317.1m
A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.
SVE
zł4.38
7D
-0.2%
1Y
0.2%
Bioerg Spólka Akcyjna
Market Cap: zł13.8m
Bioerg Spólka Akcyjna engages in the retail trade of food and chemical products for humans and animals in Poland.
BER
zł0.14
7D
0%
1Y
-17.6%